Greek Registry - Familial Hypercholesterolaemia (GRegistry-FH)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03140605|
Recruitment Status : Recruiting
First Posted : May 4, 2017
Last Update Posted : February 27, 2019
|Condition or disease|
In contrast, timely recognition and effective treatment of FH can result in a significant improvement in clinical outcomes. The problem is that that majority of individuals with FH are unaware of their disease, particularly that the disease remains silent for many years. In most countries around the world <5% of individuals with FH are identified .
Until lately the prevalence of heFH was traditionally considered to be ~ 1:500 individuals , although clinical and genetic studies suggest that heFH affects ~ 1:200-250 individuals . Thus, the aim of the Hellenic College of Treatment of Atherosclerosis (HCAT) is to 1). Evaluate the prevalence of FH in Greece (FHG-Registry) and 2). To inform population of FH disease.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||1000 participants|
|Target Follow-Up Duration:||1 Month|
|Official Title:||Hellenic Registry for Familial Hypercholesterolemia|
|Actual Study Start Date :||January 10, 2017|
|Estimated Primary Completion Date :||December 10, 2019|
|Estimated Study Completion Date :||December 10, 2019|
- the prevalence of Familiar Hypercholesterolaemia in Greece [ Time Frame: 1 month ]patients with FH will be screened and include in Registry
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03140605
|Contact: Genovefa Kolovou, MDemail@example.com|
|Onassis Cardiology Hospital||Recruiting|
|Contact: Genovefa Kolovou, MD|